Table 1. Univariate and multivariate analysis of overall survival in TCGA patients with ccRCC.
Variables | Univariate analyses | Multivariate analyses | ||
---|---|---|---|---|
Hazard ratio (95% CI) | p -value | Hazard ratio (95% CI) | p -value | |
Age (<60 vs. ≥60) | 0.557 (0.406–0.746) | <0.001 | 0.681 (0.487–0.953) | 0.025 |
Sex (female vs. male) | 1.056 (0.773–1.442) | 0.734 | ||
Laterality (left vs. right) | 1.409 (1.042–1.904) | 0.026 | 1.345 (0.972–1.860) | 0.073 |
NEDD4L (low vs. high) | 2.323 (1.683–3.208) | <0.001 | 1.905 (1.330–2.730) | <0.001 |
T (T1 vs. T2/3/4) | 0.336 (0.240–0.470) | <0.001 | 1.328 (0.707–2.495) | 0.378 |
N (N0 vs.N1/X) | 1.106 (0.819–1.493) | 0.511 | ||
M (M0 vs. M1/X) | 0.265 (0.195–0.362) | <0.001 | 0.828 (0.558–1.231) | 0.351 |
Cancer status (tumor free vs. with tumor) | 0.195 (0.140–0.273) | <0.001 | 0.334 (0.225–0.495) | <0.001 |
Stage (stage I vs. stage II/III/IV) | 0.253 (0.183–0.349) | <0.001 | 0.447 (0.240–0.834) | 0.011 |
Grade (G1/2 vs. G3/4) | 0.374 (0.265–0.529) | <0.001 | 0.759 (0.508–1.134) | 0.178 |